Alyssa Ann Grimshaw, MBA, MLIS, MPH
Biomedical Research and Methodology LibrarianDownloadHi-Res Photo
Cards
Contact Info
About
Copy Link
Titles
Biomedical Research and Methodology Librarian
Biography
Alyssa Grimshaw is a Biomedical Research and Methodology Librarian.
She earned a post-master's certificate as an interprofessional informationist at Simmons University School of Library and Information Sciences. As an information expert, she collaborates on evidence synthesis and meta-research projects. Her research interests include reproducibility, reporting, and housing impacts on public health.
Alyssa provides in-depth reference, information, research and consultation services for clinical professionals and users in the health sciences community, including literature searches in support of systematic reviews, research, grants, clinical practice, animal use, teaching, and publishing.
For more information about me, please visit please page.
Last Updated on May 27, 2025.
Departments & Organizations
Education & Training
- MPH
- Dartmouth , Public Health (2024)
- MBA
- Southern New Hampshire University, Healthcare Management (2022)
- MLIS
- Drexel University, Library & Information Sciences (2017)
Research
Copy Link
Overview
Medical Research Interests
Systematic Reviews as Topic
Public Health Interests
Women's Health; Health Informatics
ORCID
0000-0003-3985-0056
Research at a Glance
Yale Co-Authors
Frequent collaborators of Alyssa Ann Grimshaw's published research.
Publications Timeline
A big-picture view of Alyssa Ann Grimshaw's research output by year.
Research Interests
Research topics Alyssa Ann Grimshaw is interested in exploring.
Craig Gunderson, MD, SFHM
Jan Philipp Bewersdorf, MD, FACP
Nikolai Podoltsev, MD, PhD
Maximilian Stahl, MD
Amer Zeidan, MBBS, MD
Badr Al Bawardy, MD
104Publications
3,410Citations
Systematic Reviews as Topic
Publications
2026
Christian Contemplative Practices and Associations With Well-Being: A Systematic Review
Ibraheem D, Grimshaw A, Doolittle B. Christian Contemplative Practices and Associations With Well-Being: A Systematic Review. Spirituality In Clinical Practice 2026 DOI: 10.1037/scp0000415.Peer-Reviewed Original ResearchConceptsChristian contemplative practiceContemplative practicesPrayer practicesJesus PrayerContemplative prayerLectio divinaMonastic communitiesPrayerPersonal beliefsWell-beingAssociated with well-beingSystematic reviewMental health concernsPositive associationMindfulness practiceJesusChristianityDivinaLectioWeb of ScienceAPA PsycInfoPracticeWorld Health OrganizationBeliefsScholarsMenin inhibitors for patients with relapsed/refractory acute myeloid leukemia (AML): a systematic review and meta-analysis
Alhajahjeh A, Beke K, Grimshaw A, Aguirre L, Mina A, Podoltsev N, Mendez L, Stahl M, Zeidan A, Bewersdorf J. Menin inhibitors for patients with relapsed/refractory acute myeloid leukemia (AML): a systematic review and meta-analysis. Leukemia & Lymphoma 2026, ahead-of-print: 1-13. PMID: 42251692, DOI: 10.1080/10428194.2026.2682397.Peer-Reviewed Original ResearchConceptsAcute myeloid leukemiaRelapsed/Refractory Acute Myeloid LeukemiaOverall response rateMenin inhibitorsComplete responseMyeloid leukemiaTreatment-related mortalityMeta-analysisSystematic reviewLFT elevationsFebrile neutropeniaHypomethylating agentsCombination therapyNPM1 mutationsTargeted therapyDifferentiation syndromeAdverse eventsTreated patientsTherapyResponse rateCombination strategiesLeukemiaPatientsMeninInhibitorsComparative efficacy of antifungal prophylaxis in acute myeloid leukemia: A systematic review and meta-analysis.
Hunter C, Alhajahjeh A, Rajashekar N, Grimshaw A, Chou A, Roeder H, Eighmy W, Mendez L, Stahl M, Podoltsev N, Zeidan A, Shallis R, Bewersdorf J. Comparative efficacy of antifungal prophylaxis in acute myeloid leukemia: A systematic review and meta-analysis. Journal Of Clinical Oncology 2026, 44: e18515-e18515. DOI: 10.1200/jco.2026.44.16_suppl.e18515.Peer-Reviewed Original ResearchConceptsInvasive fungal infectionsAcute myeloid leukemiaInvasive fungal infection rateAntifungal prophylaxisDrug-drug interactionsSubgroup meta-analysisEfficacy of antifungal prophylaxisAntifungal prophylaxis useMyeloid leukemiaSecond-generation azolesAssociated with substantial mortality ratesIntensive therapyAntifungal prophylaxis agentComparative efficacyHigh riskSystematic reviewLess-intensive therapyHigh risk of infectionPosaconazoleAmphotericin BFungal infectionsProlonged neutropeniaRisk of infectionPediatric patientsCurrent guidelinesMortality and Infectious Adverse Events in Neutropenic Patients Undergoing Gastrointestinal Endoscopic Procedures: A Systematic Review and Meta-Analysis
Bahirwani J, Chugh R, Tran A, Ogurick A, Grimshaw A, Ciarleglio M, Deng Y, Al-Bawardy B, Hung K, Laine L. Mortality and Infectious Adverse Events in Neutropenic Patients Undergoing Gastrointestinal Endoscopic Procedures: A Systematic Review and Meta-Analysis. Gastro Hep Advances 2026, 5: 100994. PMID: 42293779, PMCID: PMC13264052, DOI: 10.1016/j.gastha.2026.100994.Peer-Reviewed Original ResearchConceptsInfectious adverse eventsInfection-related mortalityNeutropenic patientsDay of endoscopyAdverse eventsAntibiotic useMeta-analysisSafety of gastrointestinal endoscopySafety of endoscopySystematic reviewRandom-effects meta-analysesGastrointestinal endoscopic proceduresRisk of biasPooled incidenceGastrointestinal endoscopySociety guidelinesCohort studyEndoscopic proceduresWeb of ScienceCoprimary outcomesOdds ratioSecondary outcomesEndoscopyBacteremiaCochrane Library26-A-16978-ACC PREVALENCE OF OPIOID PRESCRIPTIONS IN PATIENTS WITH PERIPHERAL ARTERY DISEASE UNDERGOING REVASCULARIZATION: A SYSTEMATIC REVIEW AND META-ANALYSIS
Rodriguez A, Tapia C, Odeh O, Grimshaw A, Callegari S, Rahman M, Romain G, Hurtado C, Smolderen K. 26-A-16978-ACC PREVALENCE OF OPIOID PRESCRIPTIONS IN PATIENTS WITH PERIPHERAL ARTERY DISEASE UNDERGOING REVASCULARIZATION: A SYSTEMATIC REVIEW AND META-ANALYSIS. Journal Of The American College Of Cardiology 2026, 87: a1059. DOI: 10.1016/j.jacc.2026.02.2599.Peer-Reviewed Original ResearchAltmetricConceptsAssociation of Social Determinants of Health with Utilization of SGLT2 Inhibitors and GLP1 Receptor Agonists: A Systematic Review and Meta-Analysis
Shah N, Edjimbi J, Daou M, Grimshaw A, Gunderson C, Gupta S. Association of Social Determinants of Health with Utilization of SGLT2 Inhibitors and GLP1 Receptor Agonists: A Systematic Review and Meta-Analysis. Journal Of General Internal Medicine 2026, 1-14. PMID: 41838266, DOI: 10.1007/s11606-026-10178-z.Peer-Reviewed Reviews, Practice Guidelines, Standards, and Consensus StatementsCitationsAltmetricConceptsSocial determinants of healthSocial determinantsSocial determinants of health categoriesSystematic reviewHigh-deprivation neighborhoodsLow-SES patientsDeterminants of healthGLP-1RAOdds of utilizationMeta-analysisLower educational attainmentCross-sectional studyRisk of biasNeighborhood deprivationRandom-effects modelReceptor agonistsResultsTwenty-six studiesMethodsSix databasesPrivately insured patientsInsurance statusType 2 diabetesMetabolic riskGLP-1 receptor agonistsROBINS-I.Medicare AdvantageIncidence of acne in patients with inflammatory bowel disease treated with Janus kinase inhibitors: a systematic review and meta-analysis
Quraishi M, Alahmad M, Swaid T, Facciorusso A, Grimshaw A, Al-Bawardy B. Incidence of acne in patients with inflammatory bowel disease treated with Janus kinase inhibitors: a systematic review and meta-analysis. Inflammatory Bowel Diseases 2026, izag032. PMID: 41784155, DOI: 10.1093/ibd/izag032.Peer-Reviewed Reviews, Practice Guidelines, Standards, and Consensus StatementsCitationsAltmetricConceptsIncidence of acnePatients treated with JAK inhibitorsInflammatory bowel diseaseJanus kinase inhibitorsInflammatory bowel disease patientsPooled incidenceRandomized Controlled TrialsAdverse eventsPediatric populationJAK inhibitorsPre-specified subgroup analysesEffective oral therapyInduction phaseJanus kinaseMeta-analysisInflammatory bowel disease populationSystematic reviewInflammatory bowel disease subtypePhase of treatmentOral therapySubgroup analysisKinase inhibitorsClinical subgroupsBowel diseaseRisk factorsEfficacy and safety of immunosuppressive therapy in connective tissue disease-related immune thrombocytopenia: a systematic review and meta-analysis.
Zhang Y, Yan X, Grimshaw A, Wang Y, Li M, Zeng X, Hsieh E, Jiang N. Efficacy and safety of immunosuppressive therapy in connective tissue disease-related immune thrombocytopenia: a systematic review and meta-analysis. Therapeutic Advances In Hematology 2026, 17: 20406207261422963. PMID: 41782905, PMCID: PMC12954039, DOI: 10.1177/20406207261422963.Peer-Reviewed Reviews, Practice Guidelines, Standards, and Consensus StatementsCitationsConceptsConnective tissue diseaseImmune thrombocytopeniaImmunosuppressive therapyImmunosuppressive agentsSafety of immunosuppressive agentsGroup of autoimmune disordersSafety of immunosuppressive therapyComplete response rateSide effect incidenceNewcastle-Ottawa ScaleSystematic reviewMeta-analysis aimROBINS-I toolMantel-Haenszel formulaRandom-effects modelImmunosuppressive treatmentRelapse rateMulticenter studyTreatment regimenClinical featuresTherapy respondersAutoimmune disordersTissue diseaseSubgroup analysisSafety dataAssociation between baseline prostate MRI PI-RADS classification and risk of Gleason upgrade during active surveillance: a systematic review and meta-analysis
Smani S, Sohoni N, Miszczyk M, Fazekas T, Rajwa P, Grimshaw A, Sundaresan V, Lokeshwar S, Weinreb J, Sprenkle P, Cooperberg M, Seibert T, Shariat S, Catalona W, Leapman M. Association between baseline prostate MRI PI-RADS classification and risk of Gleason upgrade during active surveillance: a systematic review and meta-analysis. World Journal Of Urology 2026, 44: 169. PMID: 41691567, DOI: 10.1007/s00345-026-06278-4.Peer-Reviewed Reviews, Practice Guidelines, Standards, and Consensus StatementsMeSH Keywords and ConceptsConceptsPI-RADS 1PI-RADS 4Favorable risk prostate cancerRisk prostate cancerGleason grade groupPI-RADSProstate cancerMagnetic resonance imagingActive surveillanceGG upgradingRisk of biasDetection of high-grade prostate cancerRisk of Gleason upgradingHigh-grade prostate cancerProstate magnetic resonance imagingMagnetic resonance imaging findingsPI-RADS 3PI-RADS 5PI-RADS classificationPI-RADS scoreProstate Imaging-ReportingRisk of upgradeMeta-analysisRandom-effects meta-analysis modelROBINS-I toolAdvanced therapies for inflammatory bowel disease associated with primary sclerosing cholangitis: a systematic review and meta-analysis
Li D, Chaar A, Arabi T, Quraishi M, Elgamal M, Alahdab F, Grimshaw A, Al-Bawardy B. Advanced therapies for inflammatory bowel disease associated with primary sclerosing cholangitis: a systematic review and meta-analysis. Inflammatory Bowel Diseases 2026, izag001. PMID: 41677177, DOI: 10.1093/ibd/izag001.Peer-Reviewed Reviews, Practice Guidelines, Standards, and Consensus StatementsCitationsConceptsPrimary sclerosing cholangitisInflammatory bowel diseaseIBD-PSCAdvanced therapiesClinical responseAnti-TNFSclerosing cholangitisMeta-analysisConcomitant inflammatory bowel diseaseAnti-tumor necrosis factorEndoscopic remission ratesInflammatory bowel disease associated with primary sclerosing cholangitisRates of overall infectionNon-anti-TNFNon-anti-TNF biologicsSystematic reviewRandom-effects modelClinical remissionEndoscopic remissionAcute cholangitisRemission rateProspective studySubgroup analysisNecrosis factorWeb of Science
News
Copy Link
News
- November 17, 2025
Providing Dyadic Care to Mothers and Infants to Improve Health Outcomes
- April 24, 2024
Gender Gap in Promotion Within Academic Medicine
- February 14, 2024
Digital Health Tools Help Manage Hypertension for Populations Experiencing Health Disparities
- June 30, 2023
Pancreatic Cancer Risk Lower if Cysts Remain Stable for Five Years
Get In Touch
Copy Link